FDA authorizes COVID-19 antibody test’s emergency use

by on

FDA authorizes COVID-19 antibody test’s emergency use
tjordan_drupal
Oct 13, 2020

The Food and Drug Administration Oct. 12 issued an emergency use authorization for Abbott Laboratories’ AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test.

Abbott said the test, which is used on its ARCHITECT and Alinity platforms, has demonstrated high reliability in its research and external virology laboratory studies, with 99.56% specificity and 95% sensitivity for patients tested 15 days after symptom onset.

Headline

FDA authorizes COVID-19 antibody test’s emergency use
tjordan_drupal
Oct 13, 2020

The Food and Drug Administration Oct. 12 issued an emergency use authorization for Abbott Laboratories’ AdviseDx SARS-CoV-2 IgM (Immunoglobulin M) lab-based serology test.

Abbott said the test, which is used on its ARCHITECT and Alinity platforms, has demonstrated high reliability in its research and external virology laboratory studies, with 99.56% specificity and 95% sensitivity for patients tested 15 days after symptom onset.

Novel Coronavirus (COVID-19)
COVID-19: CDC, FDA and CMS Guidance

Headline

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: